BALDINI, CHIARA
 Distribuzione geografica
Continente #
NA - Nord America 10.704
EU - Europa 4.443
AS - Asia 1.925
AF - Africa 347
SA - Sud America 91
OC - Oceania 46
Continente sconosciuto - Info sul continente non disponibili 8
Totale 17.564
Nazione #
US - Stati Uniti d'America 10.379
IT - Italia 1.331
CN - Cina 1.070
SE - Svezia 978
BG - Bulgaria 581
DE - Germania 351
GB - Regno Unito 309
CA - Canada 296
VN - Vietnam 255
SG - Singapore 211
FI - Finlandia 161
AT - Austria 159
CI - Costa d'Avorio 149
TR - Turchia 117
NL - Olanda 107
UA - Ucraina 103
NG - Nigeria 101
IN - India 100
FR - Francia 83
HK - Hong Kong 81
BE - Belgio 79
SN - Senegal 78
RU - Federazione Russa 49
CH - Svizzera 46
AU - Australia 44
BR - Brasile 42
ES - Italia 31
JP - Giappone 28
MX - Messico 21
CO - Colombia 16
KR - Corea 16
PL - Polonia 16
GR - Grecia 13
TW - Taiwan 11
RO - Romania 9
EC - Ecuador 8
EU - Europa 8
IE - Irlanda 8
AR - Argentina 7
MA - Marocco 7
PE - Perù 7
IL - Israele 6
IR - Iran 5
NO - Norvegia 5
PT - Portogallo 5
AM - Armenia 4
CL - Cile 4
CZ - Repubblica Ceca 4
DK - Danimarca 4
DZ - Algeria 4
EG - Egitto 4
MY - Malesia 4
BO - Bolivia 3
HR - Croazia 3
ID - Indonesia 3
LB - Libano 3
SA - Arabia Saudita 3
UY - Uruguay 3
GT - Guatemala 2
HU - Ungheria 2
LK - Sri Lanka 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PH - Filippine 2
RE - Reunion 2
SK - Slovacchia (Repubblica Slovacca) 2
BF - Burkina Faso 1
FK - Isole Falkland (Malvinas) 1
GL - Groenlandia 1
IQ - Iraq 1
IS - Islanda 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MN - Mongolia 1
PA - Panama 1
PR - Porto Rico 1
RS - Serbia 1
SI - Slovenia 1
TH - Thailandia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 17.564
Città #
Woodbridge 1.624
Ann Arbor 1.125
Houston 1.024
Fairfield 957
Chandler 897
Sofia 580
Ashburn 541
Seattle 427
Beijing 424
New York 398
Wilmington 375
Milan 359
Cambridge 327
Princeton 276
Ottawa 261
Lawrence 233
Medford 216
Nanjing 163
Serra 152
Abidjan 149
Jacksonville 141
Des Moines 137
Florence 128
Vienna 119
Izmir 108
Dearborn 101
Lagos 101
Dong Ket 95
London 86
Bremen 84
Dakar 78
San Diego 69
Brussels 65
Hong Kong 65
Redwood City 57
Pune 52
Nanchang 50
Pisa 48
Rome 46
Falls Church 42
Frankfurt am Main 42
Lancaster 39
Kunming 38
Bern 36
Shenyang 36
Hefei 35
Hebei 34
Boulder 33
Jüchen 31
Boardman 30
Amsterdam 28
Marseille 28
Shanghai 28
Jiaxing 26
Changsha 24
Ogden 24
Guangzhou 21
Norwalk 19
Tianjin 18
Trani 16
Düsseldorf 15
Hangzhou 15
Indiana 14
Jinan 14
Melbourne 13
Warsaw 13
Leeuwarden 12
Los Angeles 12
Maastricht 12
Chongqing 11
Fuzhou 11
Leuven 11
Livorno 11
Palermo 11
Phoenix 11
Houten 10
Montecatini Terme 10
Singapore 10
Wuhan 10
Barcelona 9
Duncan 9
Grafing 9
Redmond 9
Washington 9
Zhengzhou 9
Arezzo 8
Chengdu 8
Leeds 8
Madrid 8
Saint Petersburg 8
Taipei 8
Bari 7
Cascina 7
Council Bluffs 7
Dublin 7
Paris 7
Auburn Hills 6
Boston 6
Chicago 6
Genoa 6
Totale 13.153
Nome #
Sjögren syndrome 791
IN THE CHRONIC MYELOID LEUKEMIA THE SALIVARY PROTEOMICS RECAPITULATES SOME ASPECTS OF THE LEUKEMIC STEM CELL. LA CELLULA STAMINALE LEUCEMICA E LA PROTEOMICA SALIVARE: IL MODELLO DELLA LEUCEMIA MIELOIDE CRONICA 156
Classification criteria 141
A proposal of simple calculation (ERI calculator) to predict the early response to TNF-a blockers therapy in rheumatoid arthritis 139
Behçet's disease: features of neurological involvement in a dedicated centre in Italy. 139
Correspondence between salivary proteomic pattern and clinical course in primary Sjogren syndrome and non-Hodgkin's lymphoma: a case report 139
Fibronectin gene polymorphisms are associated with the development of B-cell lymphoma in type II mixed cryoglobulinemia. 137
[Churg-Strauss vasculitis and idiopathic hypereosinophyl syndrome: role of molecular biology in the differential diagnosis of hypereosinophyl syndrome] 129
Anti-Sm and anti-RNP antibodies 129
Gross Cystic Disease Fluid Protein-15(GCDFP-15)/Prolactin-Inducible Protein (PIP) as Functional Salivary Biomarker for Primary Sjögren's Syndrome 128
TCR REARRANGEMENTS ARE NOT ENOUGH FOR DISTINGUISHING THE CHURG-STRAUSS SYNDROME FROM THE HYPEREOSINOPHILIC SYNDROME 123
Sjögren's Syndrome Disease Damage Index and disease activity index: scoring systems for the assessment of disease damage and disease activity in Sjögren's syndrome, derived from an analysis of a cohort of Italian patients 119
Skin manifestations and sjögren’s syndrome 117
Efficacy and safety of rituximab in HCV-related mixed cryoglobulinemia 116
A Clinical Prediction Rule for Lymphoma Development in Primary Sjogren's Syndrome 116
In vivo confocal scanning laser microscopy in patients with primary Sjögren's syndrome: A monocentric experience. 116
Clinical manifestations and treatment of Churg-Strauss syndrome 116
Classification criteria for Sjogren's syndrome: A critical review. 113
Classification criteria for Sjogren's syndrome: A critical review. 113
Impact of joint involvement on patients reported outcomes in systemic lupus erythematosus. 113
EXTENSIVE ANALYSIS OF T CELL RECEPTOR GAMMA (TCRG) GENE REARRANGEMENTS REVEALS A SIMILAR REPERTOIRE IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA) AND IN HYPEREOSINOPHILIC SYNDROME (HES) 113
Discontinuation rates and timing of antimalarial drugs in primary Sjögren's syndrome. 111
Occurrence of organ-specific and systemic autoimmune diseases among the first- and second-degree relatives of Caucasian patients with connective tissue diseases: report of data obtained through direct patient interviews 111
Muscular vasculitis confined to lower limbs: description of two case reports and a review of the literature 110
Churg-Strauss syndrome: clinical and serological features of 19 patients from a single Italian centre. 109
Treatment of chronic hepatitis C infection with cryoglobulinemia. 108
Mucocutaneous manifestations of Sjögren's Syndrome 107
Churg-Strauss vasculitis and idiopathic hypereosinophyl syndrome: role of molecular biology in the differential diagnosis of hypereosinophyl syndrome 107
Minor salivary gland biopsy and Sjögren's syndrome: comparative analysis of biopsies among different Italian rheumatologic centers 107
null 107
Skin manifestations and cryoglobulinemia 107
null 107
Occurrence of hashimoto thyroiditis among the first- and second-degree relatives of systemic lupus erythematosus patients with Hashimoto thyroiditis 107
Analysis of the evolution of UCTD to defined CTD after a long-term follow-up. 106
Changes of flow mediated dilation in pregnant patients with systemic autoimmune diseases 106
Is GRP78/BiP a potential salivary biomarker in patients with rheumatoid arthritis? 104
TNF-alpha inhibitors in Systemic Lupus Erythematosus. A case report and a systematic literature review 104
null 104
Proteomic diagnosis of Sjögren's syndrome 104
Undifferentiated connective tissue diseases (UCTD) 102
null 102
miRNA-mediated regulation of Mucin-type O-Glycosylation pathway: a putative mechanism of salivary gland dysfunction in Sjögren's syndrome 101
Artrite reumatoide e analisi proteomica della saliva 100
Alteration of microcirculation is a hallmark of very early systemic sclerosis patients: a laser speckle contrast analysis. 100
Proteomics approach as a tool for salivary fingerprint characterization able to discriminate different Sjögren’s syndrome phenotype. 100
Proteome analysis of whole saliva: a new tool for rheumatic diseases--the example of Sjögren's syndrome. 100
Impact of joint involvement on patients reported outcomes in systemic lupus erythematosus 99
A Clinical prediction rule for lymphoma development in primary and secondary Sjogren’s syndrome. 97
Emerging trends in Sjögren's syndrome: basic and translational research. 97
Rhupus syndrome: Assessment of its prevalence and its clinical and instrumental characteristics in a prospective cohort of 103 SLE patients. 96
The WNT pathway is relevant for the BCR-ABL1-independent resistance in chronic myeloid leukemia 95
null 94
null 94
Proteomic analysis of the saliva: A clue for understanding primary from secondary Sjogren's syndrome? 94
The economic impact of gout: a systematic literature review. 92
null 92
null 92
null 92
Current Concepts on Classification Criteria and Disease Status Indexes in Sjögren’s Syndrome 91
Undifferentiated connective tissue diseases in 2004 91
Outcome of pregnancy in Italian patients with primary Sjögren syndrome 91
null 91
null 91
Primary Sjogren's Syndrome: clinical and serological feature of a single centre [Sindrome di Sjogren primitiva: Descrizione clinica e sierologica di una casistica monocentrica] 90
Cystatin S-a candidate biomarker for severity of submandibular gland involvement in Sjögren's syndrome 90
null 89
The association of Sjögren syndrome and autoimmune thyroid disorders 89
Specific proteins identified in whole saliva from patients with diffuse systemic sclerosis 88
A retrospective, multicenter study evaluating the prognostic value of minor salivary gland histology in a large cohort of patients with primary Sjögren's syndrome. 88
Detection of potential markers of primary fibromyalgia syndrome in human saliva 88
Minor salivary gland biopsy and Sjögren's syndrome: comparative analysis of biopsies among different Italian rheumatologic centers. 87
LJP-394 (abetimus sodium) in the treatment of systemic lupus erythematosus 86
Updates on Sjögren's syndrome: from proteomics to protein biomarkers 86
null 86
Biomarkers for Sjögren's syndrome 86
null 85
Eosinophilic granulomatosis with polyangiitis and laryngeal involvement: Review of the literature and a cross-sectional prospective experience 85
Proteomic analysis of saliva: a unique tool to distinguish primary Sjogren's syndrome from secondary Sjogren's syndrome and other sicca syndromes 84
Occurrence of organ-specific and systemic autoimmune diseases among the first- and second-degree relatives of Caucasian patients with connective tissue diseases: report of data obtained through direct patient interviews 84
MALDI-TOF and SELDI-TOF analysis: "tandem" techniques to identify potential biomarker in fibromyalgia. [MALDI-TOF e SELDI-TOF: due tecniche “tandem” per l’individuazione di potenziali biomarker nella fibromialgia] 84
Omalizumab: a novel steroid sparing agent in eosinophilic granulomatosis with polyangiitis? 83
null 83
Phenotyping multiple subsets in Sjögren’s syndrome: a salivary proteomic SWATH-MS approach towards precision medicine 83
Ultrasound imaging for the rheumatologist. XXIII. Sonographic evaluation of hand joint involvement in primary Sjogren's Syndrome 81
null 81
Sjogren's Syndrome Disease Damage Index and disease activity index: scoring systems for the assessment of disease damage and disease activity in Sjogren's syndrome, derived from an analysis of a cohort of Italian patients 81
Celiac Disease Prevalence is Increased in Primary Sjögren's Syndrome and Diffuse Systemic Sclerosis: Lessons from a Large Multi-Center Study 81
Mikulicz's disease: a long-term follow-up case report. 80
Skin involvment and outcome measures in systemic autoimmune diseases 80
The value of outcome measures in autoimmune rheumatic diseases 79
Saliva as an ideal milieu for emerging diagnostic approaches in primary Sjögren's syndrome. 79
Large- and small-vessel vasculitis: a critical digest of the \2010-2011 literature. 78
Alteration of microcirculation is a hallmark of very early systemic sclerosis patients: a laser speckle contrast analysis. 78
null 78
How HCV has changed the approach to mixed cryoglobulinemia 77
null 77
Patterns of inflammation and dysfunction in pSS: identification of proteomic salivary biomarkers correlated with different disease phenotypes. 77
Classification criteria in Sjögren’s syndrome 77
TCR GAMMA CLONALITY ASSESSED BY NGS DOES NOT HELP TO DISTINGUISH EGPA FROM HES 77
Association of psoriasin (S100A7) with clinical manifestations of systemic sclerosis: Is its presence in whole saliva a potential predictor of pulmonary involvement? 76
Totale 10.584
Categoria #
all - tutte 45.724
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.724


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.059 0 0 0 0 0 0 0 0 119 287 348 305
2019/20202.726 387 280 132 184 251 314 262 196 217 217 213 73
2020/20211.444 78 58 49 61 106 178 77 104 173 112 112 336
2021/20222.623 47 180 39 168 473 377 98 136 134 97 161 713
2022/20233.487 437 428 247 287 406 378 61 251 580 59 274 79
2023/20242.183 287 260 286 192 397 503 138 70 50 0 0 0
Totale 18.271